Tassiane Cristine Santos de Paula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tassiane Cristine Santos de Paula has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Camila Chagas
Department of Psychobiology Universidade Federal de São Paulo‐UNIFESP São Paulo Brazil
8 shared publications - Cleusa Pinheiro Ferri
Department of Psychiatry Escola Paulista de Medicina Universidade Federal de São Paulo São Paulo Brazil
4 shared publications Cleusa P. Ferri
Departments of Psychobiology and Psychiatry, Universidade Federal de São Paulo
3 shared publications- José Carlos Fernandes Galduróz
Federal University of São Paulo
3 shared publications - Rosa Camila Lucchetta
Health Technology Assessment Unit, Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo, Brazil
3 shared publications - Amanda E. G. Henrique
Department of Psychobiology, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 49 (1)
Update of the Brazilian Clinical Practice Guideline for primary immune thrombocytopenia: methodological process and main changes for diagnosis and treatment in the Brazilian Unified Health System (SUS)
- 27 October 2026
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 49 (1)
Open AccessUpdate of the Brazilian Clinical Practice Guideline for primary immune thrombocytopenia: methodological process and main changes for diagnosis and treatment in the Brazilian Unified Health System (SUS)
- Open Access
- 27 August 2026
- Published by Wiley in Nursing & Health Sciences
- Vol. 28 (3) , e70418
Walking Together: A Cross‐Cultural Study of the Relationship Between Religiosity and Substance Use Disorder
The literature suggests that religiosity is a protective factor for substance use. However, individuals with substance use disorder (SUD) may actively cultivate their religiosity during substance use. This qualitative study analyzed the perceptions and meanings homeless people attribute to their substance use trajectories and religiosity, as well as the potential connections between these two themes. The analysis was conducted based on the content analysis technique proposed by Bardin. A total of 40 semi‐structured interviews were conducted with 20 Brazilian and 20 Portuguese participants. The present study found that religiosity can play a role in the substance use trajectory and the development of SUD by offering a subjective sense of protection, serving as a marker for the need for change, or providing relief from the suffering associated with SUD. We discuss how homeless people with SUD experience religiosity and how religious aspects traditionally seen as protective in the literature, such as church attendance, may paradoxically become risk factors for these socially vulnerable populations.
- 27 August 2026
- Published by Wiley in Nursing & Health Sciences
- Vol. 28 (3) , e70418
Open AccessWalking Together: A Cross‐Cultural Study of the Relationship Between Religiosity and Substance Use Disorder
The literature suggests that religiosity is a protective factor for substance use. However, individuals with substance use disorder (SUD) may actively cultivate their religiosity during substance use. This qualitative study analyzed the perceptions and meanings homeless people attribute to their substance use trajectories and religiosity, as well as the potential connections between these two themes. The analysis was conducted based on the content analysis technique proposed by Bardin. A total of 40 semi‐structured interviews were conducted with 20 Brazilian and 20 Portuguese participants. The present study found that religiosity can play a role in the substance use trajectory and the development of SUD by offering a subjective sense of protection, serving as a marker for the need for change, or providing relief from the suffering associated with SUD. We discuss how homeless people with SUD experience religiosity and how religious aspects traditionally seen as protective in the literature, such as church attendance, may paradoxically become risk factors for these socially vulnerable populations.
- Open Access
- 19 May 2025
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 51, 1-8
Custo-efetividade do romosozumabe seguido de alendronato versus alendronato para o tratamento de osteoporose grave em mulheres na pós-menopausa com muito alto risco de fratura para o SUS
Introdução: A osteoporose, especialmente em mulheres na pós-menopausa, é uma condição que aumenta o risco de fraturas e gera elevados custos com tratamento. O romosozumabe, combinado ao alendronato, mostra eficácia no tratamento, mas seu alto custo pode limitar sua utilização no SUS. Objetivo: Analisar o custo-efetividade do uso de romosozumabe seguido de alendronato comparado ao uso de alendronato isolado, no tratamento da osteoporose grave em mulheres na pós-menopausa, com muito alto risco de fraturas, no contexto do Sistema Único de Saúde (SUS). Material e Métodos: Foi proposto um modelo de estados transicionais do tipo cadeias de Markov de cinco estados, lifetime (16 anos) e considerado como desfecho ano de vida ajustado pela qualidade (QALY). Foram incluídos os custos diretos do tratamento hospitalar e ambulatorial. Análises de sensibilidade probabilística e determinística foram conduzidas. Valor de referência de custo-efetividade definido em R$ 40 a 120 mil por QALY ganho (2022). Resultados: Foi identificado benefício (98% das simulações) e custo (100% das simulações) incrementais com 0,07 QALY ganho e custo incremental de R$ 23,4 mil para romosozumabe seguido de alendronato, resultando em uma razão de custo-efetividade incremental (RCEI) de R$ 356,6 mil para cada QALY ganho na análise determinística. Análises de sensibilidade determinística indicam variação da RCEI de R$ 226 a R$ 540 mil, a depender do valor de utility considerado no estado inicial (variável mais influente). Conclusão: O tratamento com romosozumabe não foi considerado custo-efetivo para o SUS. Apesar disso, o medicamento foi incorporado ao sistema em 2022 e, para contribuir para a sustentabilidade do sistema, é importante que os critérios de indicação do medicamento sejam rigorosamente respeitados, bem como que reduções de preço sejam pleiteadas.
- 19 May 2025
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 51, 1-8
Open AccessCusto-efetividade do romosozumabe seguido de alendronato versus alendronato para o tratamento de osteoporose grave em mulheres na pós-menopausa com muito alto risco de fratura para o SUS
Introdução: A osteoporose, especialmente em mulheres na pós-menopausa, é uma condição que aumenta o risco de fraturas e gera elevados custos com tratamento. O romosozumabe, combinado ao alendronato, mostra eficácia no tratamento, mas seu alto custo pode limitar sua utilização no SUS. Objetivo: Analisar o custo-efetividade do uso de romosozumabe seguido de alendronato comparado ao uso de alendronato isolado, no tratamento da osteoporose grave em mulheres na pós-menopausa, com muito alto risco de fraturas, no contexto do Sistema Único de Saúde (SUS). Material e Métodos: Foi proposto um modelo de estados transicionais do tipo cadeias de Markov de cinco estados, lifetime (16 anos) e considerado como desfecho ano de vida ajustado pela qualidade (QALY). Foram incluídos os custos diretos do tratamento hospitalar e ambulatorial. Análises de sensibilidade probabilística e determinística foram conduzidas. Valor de referência de custo-efetividade definido em R$ 40 a 120 mil por QALY ganho (2022). Resultados: Foi identificado benefício (98% das simulações) e custo (100% das simulações) incrementais com 0,07 QALY ganho e custo incremental de R$ 23,4 mil para romosozumabe seguido de alendronato, resultando em uma razão de custo-efetividade incremental (RCEI) de R$ 356,6 mil para cada QALY ganho na análise determinística. Análises de sensibilidade determinística indicam variação da RCEI de R$ 226 a R$ 540 mil, a depender do valor de utility considerado no estado inicial (variável mais influente). Conclusão: O tratamento com romosozumabe não foi considerado custo-efetivo para o SUS. Apesar disso, o medicamento foi incorporado ao sistema em 2022 e, para contribuir para a sustentabilidade do sistema, é importante que os critérios de indicação do medicamento sejam rigorosamente respeitados, bem como que reduções de preço sejam pleiteadas.
- Open Access
- 16 January 2024
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 49, 1-11
Eficácia e segurança de romosozumabe para o tratamento de osteoporose grave em mulheres na pós-menopausa: revisão sistemática e meta-análise em rede
Introdução: A osteoporose é uma das principais causas de morbimortalidade, principalmente em idosos e mulheres na pós-menopausa, devido ao aumento da fragilidade óssea e maior suscetibilidade a fraturas. Objetivo: Avaliar a eficácia e segurança do romosozumabe, comparado aos tratamentos farmacológicos atualmente disponíveis no Sistema Único de Saúde para o manejo de mulheres na pós-menopausa com osteoporose grave e alto risco de fraturas. Métodos: Foi realizada uma busca seguida por meta-análises indiretas, por ensaios clínicos randomizados (ECR) nas bases PubMed Central e Medline, Embase e Cochrane Library e por busca manual. O risco de viés (RoB 2.0) e a qualidade da evidência (GRADE) foram analisados. Meta-análises indiretas foram realizadas para desfechos de fraturas, densidade mineral óssea e eventos adversos. Resultados: Sete ECR (n= 19.951 mulheres) foram incluídos nesta revisão. Romosozumabe seguido de alendronato reduziu risco de fraturas não vertebrais em 12 meses (RR: 0,64, IC 95%: 0,49-0,84; alta certeza de evidência) e em 24 meses (RR: 0,52, IC 95%: 0,43-0,64; (alta certeza de evidência) na comparação ao alendronato. Achados semelhantes foram identificados para outros desfechos. Ácido zoledrônico foi associada a maior risco de descontinuação por evento adverso que placebo (RR: 1,02, IC 95%: 1,01-1,03). Conclusão: Foi identificado que romosozumabe ou romosozumabe seguido por alendronato são eficazes e seguros na comparação com alendronato.
- 16 January 2024
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 49, 1-11
Open AccessEficácia e segurança de romosozumabe para o tratamento de osteoporose grave em mulheres na pós-menopausa: revisão sistemática e meta-análise em rede
Introdução: A osteoporose é uma das principais causas de morbimortalidade, principalmente em idosos e mulheres na pós-menopausa, devido ao aumento da fragilidade óssea e maior suscetibilidade a fraturas. Objetivo: Avaliar a eficácia e segurança do romosozumabe, comparado aos tratamentos farmacológicos atualmente disponíveis no Sistema Único de Saúde para o manejo de mulheres na pós-menopausa com osteoporose grave e alto risco de fraturas. Métodos: Foi realizada uma busca seguida por meta-análises indiretas, por ensaios clínicos randomizados (ECR) nas bases PubMed Central e Medline, Embase e Cochrane Library e por busca manual. O risco de viés (RoB 2.0) e a qualidade da evidência (GRADE) foram analisados. Meta-análises indiretas foram realizadas para desfechos de fraturas, densidade mineral óssea e eventos adversos. Resultados: Sete ECR (n= 19.951 mulheres) foram incluídos nesta revisão. Romosozumabe seguido de alendronato reduziu risco de fraturas não vertebrais em 12 meses (RR: 0,64, IC 95%: 0,49-0,84; alta certeza de evidência) e em 24 meses (RR: 0,52, IC 95%: 0,43-0,64; (alta certeza de evidência) na comparação ao alendronato. Achados semelhantes foram identificados para outros desfechos. Ácido zoledrônico foi associada a maior risco de descontinuação por evento adverso que placebo (RR: 1,02, IC 95%: 1,01-1,03). Conclusão: Foi identificado que romosozumabe ou romosozumabe seguido por alendronato são eficazes e seguros na comparação com alendronato.
- 13 December 2022
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 58 (2) , 238-256
A Systematic Review on Alcohol Consumption among Non-Religious and Religious Adults
Background: Research has suggested that religiosity is a protective factor in alcohol use, but this is an area that could be further explored. Objective: To undertake a systematic review of the literature on drinking patterns and their relationship with religiosity and non-religiosity in adult populations. Methods: We searched for relevant studies using the PubMed, LILACS, Web of Science, Scopus, and Psych-INFO databases. This review included only studies of people aged 18 and over which had a non-religious group as a comparison measure. Results: Fifty-one studies met the inclusion criteria. The present review showed that religious people tend to have lower alcohol consumption compared to those with no religion. However, this difference appears only when religions are analyzed together without differentiating between religious affiliations (Catholicism, Buddhism, Evangelicalism, etc.). Some religious affiliations, such as Buddhism, Catholicism and Lutheranism, appear to be risk factors for alcohol consumption. Definitions of risk consumption showed high heterogeneity, ranging from eight to 21 or more doses per week, a difference of 13 doses of alcohol between studies. Conclusions: The present review showed that religious people tend to have lower alcohol consumption compared to non-religious people. However, the results are contradictory when religious affiliations are analyzed separately and compared with non-religious participants. Adequately understanding which dimensions of religiosity and non-religiosity (e.g., group processes, engagement, meaning, rules of behavior) are protective in adulthood is fundamental to the construction of more effective interventions in this age group.
- 13 December 2022
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 58 (2) , 238-256
A Systematic Review on Alcohol Consumption among Non-Religious and Religious Adults
Background: Research has suggested that religiosity is a protective factor in alcohol use, but this is an area that could be further explored. Objective: To undertake a systematic review of the literature on drinking patterns and their relationship with religiosity and non-religiosity in adult populations. Methods: We searched for relevant studies using the PubMed, LILACS, Web of Science, Scopus, and Psych-INFO databases. This review included only studies of people aged 18 and over which had a non-religious group as a comparison measure. Results: Fifty-one studies met the inclusion criteria. The present review showed that religious people tend to have lower alcohol consumption compared to those with no religion. However, this difference appears only when religions are analyzed together without differentiating between religious affiliations (Catholicism, Buddhism, Evangelicalism, etc.). Some religious affiliations, such as Buddhism, Catholicism and Lutheranism, appear to be risk factors for alcohol consumption. Definitions of risk consumption showed high heterogeneity, ranging from eight to 21 or more doses per week, a difference of 13 doses of alcohol between studies. Conclusions: The present review showed that religious people tend to have lower alcohol consumption compared to non-religious people. However, the results are contradictory when religious affiliations are analyzed separately and compared with non-religious participants. Adequately understanding which dimensions of religiosity and non-religiosity (e.g., group processes, engagement, meaning, rules of behavior) are protective in adulthood is fundamental to the construction of more effective interventions in this age group.
- 21 February 2022
- Published by Taylor & Francis in Aging & Mental Health
- Vol. 27 (4) , 797-802
Late-life drinking and smoking in primary care users in Brazil
To estimate the prevalence of at-risk drinking and smoking and associated factors among older adults in primary care in Brazil. A cross-sectional study carried out in seven primary care units with 503 older adults (60+), in a city in the state of Sao Paulo, Brazil. At-risk drinking was defined by AUDIT-C and by consumption of units per week. Poisson regression was used to assess the association between the sociodemographic and health characteristics and smoking and at-risk drinking. The median age of the 503 participants was 69.6 (SD ± 6.7; range:60-93). One third of participants (33.6%) were current drinkers, 16% were at-risk drinkers (AUDIT-C), 4% at-risk drinkers (units per week), and 13% of the sample were regular smokers. The prevalence of at-risk drinking (AUDIT-C) was higher for males (RP: 4.89; 95% CI: 2.52–9.49) and for those with higher levels of education (RP: 1,861.85 95% CI: 1.08–3.14), and lower for those over the age of 70 (RP: 0.50; 95% CI: 0.30-0.84). The prevalence of smoking was higher for those with depressive symptoms (RP: 1.95; 95% CI: 1.03-3.66), and lower for those over age 70 (RP: 0.52; 95% CI: 0.29-0.94). The results point to a set of factors associated with at-risk drinking (being male, younger and having a higher education), and with smoking (being younger and having depressive symptoms). Our findings could help health professionals to identify at-risk drinkers and smokers, as well as support strategies for future interventions by the identification of the groups most vulnerable to these behaviors.
- 21 February 2022
- Published by Taylor & Francis in Aging & Mental Health
- Vol. 27 (4) , 797-802
Late-life drinking and smoking in primary care users in Brazil
To estimate the prevalence of at-risk drinking and smoking and associated factors among older adults in primary care in Brazil. A cross-sectional study carried out in seven primary care units with 503 older adults (60+), in a city in the state of Sao Paulo, Brazil. At-risk drinking was defined by AUDIT-C and by consumption of units per week. Poisson regression was used to assess the association between the sociodemographic and health characteristics and smoking and at-risk drinking. The median age of the 503 participants was 69.6 (SD ± 6.7; range:60-93). One third of participants (33.6%) were current drinkers, 16% were at-risk drinkers (AUDIT-C), 4% at-risk drinkers (units per week), and 13% of the sample were regular smokers. The prevalence of at-risk drinking (AUDIT-C) was higher for males (RP: 4.89; 95% CI: 2.52–9.49) and for those with higher levels of education (RP: 1,861.85 95% CI: 1.08–3.14), and lower for those over the age of 70 (RP: 0.50; 95% CI: 0.30-0.84). The prevalence of smoking was higher for those with depressive symptoms (RP: 1.95; 95% CI: 1.03-3.66), and lower for those over age 70 (RP: 0.52; 95% CI: 0.29-0.94). The results point to a set of factors associated with at-risk drinking (being male, younger and having a higher education), and with smoking (being younger and having depressive symptoms). Our findings could help health professionals to identify at-risk drinkers and smokers, as well as support strategies for future interventions by the identification of the groups most vulnerable to these behaviors.
- 11 November 2021
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 37 (1)
Alcohol consumption among older adults: Findings from the ELSI‐Brazil study
Objectives: This study estimates the national prevalence of drinking patterns (current, heavy, and binge) and the associated factors, among older Brazilians.Design: Cross‐sectional study using survey data from ELSI‐Brazil (2015–2016).Setting/Participants: A total of 7839 adults aged 50 years or older.Measurements: Respondents were asked about alcohol drinking. Alcohol consumption status was categorized as current drinkers (last month), heavy drinkers (≥7 drinks/week for females and ≥14 drinks/week for males), and binge drinkers (≥4 drinks on one occasion for females and ≥5 drinks on one occasion for males). Covariates included sociodemographic characteristics, tobacco smoking, depression, and number of chronic diseases.Results: Of the 7839 participants, 29.4% were current drinkers, 5.1% were heavy drinkers, and 10.3% reported binge drinking. In the ≥60 years old age group, the prevalence of current drinking was 23.8%, 3.9% were heavy drinkers, and 6.7% reported binge drinking. All drinking patterns had similar associated factors: being male, being younger, having higher education, tobacco smoking, and falls. In addition, the greater the number of chronic conditions, the lower the prevalence of current drinking and binge drinking.Conclusion: Heavy drinking and binge drinking are often reported by older Brazilians, particularly among males, those with higher education and in the younger age groups. These behaviors can negatively affect the health of older adults. It is, therefore, important to identify the problems related to alcohol consumption among older adults to minimize the risks and harms.
- 11 November 2021
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 37 (1)
Alcohol consumption among older adults: Findings from the ELSI‐Brazil study
Objectives: This study estimates the national prevalence of drinking patterns (current, heavy, and binge) and the associated factors, among older Brazilians.Design: Cross‐sectional study using survey data from ELSI‐Brazil (2015–2016).Setting/Participants: A total of 7839 adults aged 50 years or older.Measurements: Respondents were asked about alcohol drinking. Alcohol consumption status was categorized as current drinkers (last month), heavy drinkers (≥7 drinks/week for females and ≥14 drinks/week for males), and binge drinkers (≥4 drinks on one occasion for females and ≥5 drinks on one occasion for males). Covariates included sociodemographic characteristics, tobacco smoking, depression, and number of chronic diseases.Results: Of the 7839 participants, 29.4% were current drinkers, 5.1% were heavy drinkers, and 10.3% reported binge drinking. In the ≥60 years old age group, the prevalence of current drinking was 23.8%, 3.9% were heavy drinkers, and 6.7% reported binge drinking. All drinking patterns had similar associated factors: being male, being younger, having higher education, tobacco smoking, and falls. In addition, the greater the number of chronic conditions, the lower the prevalence of current drinking and binge drinking.Conclusion: Heavy drinking and binge drinking are often reported by older Brazilians, particularly among males, those with higher education and in the younger age groups. These behaviors can negatively affect the health of older adults. It is, therefore, important to identify the problems related to alcohol consumption among older adults to minimize the risks and harms.
- Open Access
Brief interventions for older adults (BIO) delivered by non-specialist community health workers to reduce at-risk drinking in primary care: a study protocol for a randomised controlled trial
Introduction: Evidence suggests that brief interventions are effective in reducing alcohol consumption among older adults. However, the effectiveness of these interventions when delivered by community health workers (non-specialists) in a primary healthcare setting is unknown. To our knowledge, this will be the first randomised trial to examine this. Methods and analysis: Two hundred and forty-two individuals considered at-risk drinkers (Alcohol Use Disorders Identification Test-Consumption, AUDIT-C score ≥4) will be recruited and randomly allocated to usual care (waiting-list) or usual care plus an intervention delivered by trained community health workers (non-specialists). Seven primary care units (PCUs) in Sao José dos Campos, Brazil. PCUs are part of the Brazilian public healthcare system (Sistema Único de Saúde). Follow-up 6 months. Outcomes The primary outcome will be the proportion of participants considered at-risk drinkers (AUDIT-C score ≥4). Secondary outcomes will include alcohol consumption in a typical week in the last 30 days (in units per week) assessed by the AUDIT, service use questionnaire, cognitive performance—assessed by The Health and Retirement Study Harmonised Cognitive Assessment, physical activity—assessed by the International Physical Activity Questionnaire, depression—assessed by the Geriatric Depression Scale and quality of life—assessed by the Control, Autonomy, Self-realisation and Pleasure-16 instrument. The analysis will be based on intention-to-treat principle. Ethics and dissemination: This study has been approved by the Ethics Committee of the Universidade Federal de São Paulo, CEP/UNIFESP Project n: 0690/2018; CAAE: 91648618.0.0000.5505. All eligible participants will provide informed consent prior to randomisation. The results of this study will be published in relevant peer-reviewed journals and in conference presentations. Trial registration number: RBR-8rcxkk.
Open AccessBrief interventions for older adults (BIO) delivered by non-specialist community health workers to reduce at-risk drinking in primary care: a study protocol for a randomised controlled trial
Introduction: Evidence suggests that brief interventions are effective in reducing alcohol consumption among older adults. However, the effectiveness of these interventions when delivered by community health workers (non-specialists) in a primary healthcare setting is unknown. To our knowledge, this will be the first randomised trial to examine this. Methods and analysis: Two hundred and forty-two individuals considered at-risk drinkers (Alcohol Use Disorders Identification Test-Consumption, AUDIT-C score ≥4) will be recruited and randomly allocated to usual care (waiting-list) or usual care plus an intervention delivered by trained community health workers (non-specialists). Seven primary care units (PCUs) in Sao José dos Campos, Brazil. PCUs are part of the Brazilian public healthcare system (Sistema Único de Saúde). Follow-up 6 months. Outcomes The primary outcome will be the proportion of participants considered at-risk drinkers (AUDIT-C score ≥4). Secondary outcomes will include alcohol consumption in a typical week in the last 30 days (in units per week) assessed by the AUDIT, service use questionnaire, cognitive performance—assessed by The Health and Retirement Study Harmonised Cognitive Assessment, physical activity—assessed by the International Physical Activity Questionnaire, depression—assessed by the Geriatric Depression Scale and quality of life—assessed by the Control, Autonomy, Self-realisation and Pleasure-16 instrument. The analysis will be based on intention-to-treat principle. Ethics and dissemination: This study has been approved by the Ethics Committee of the Universidade Federal de São Paulo, CEP/UNIFESP Project n: 0690/2018; CAAE: 91648618.0.0000.5505. All eligible participants will provide informed consent prior to randomisation. The results of this study will be published in relevant peer-reviewed journals and in conference presentations. Trial registration number: RBR-8rcxkk.
- 1 May 2021
- Published by Springer Nature
- p. 71-82
Substance Use Among Older Adults: Epidemiological Aspects, Associated Variables, and Organic Risks
- 1 May 2021
- Published by Springer Nature
- p. 71-82
Substance Use Among Older Adults: Epidemiological Aspects, Associated Variables, and Organic Risks
- Open Access
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 30 (1) , e2020921
A linguagem e o estigma: os termos utilizados na área de álcool e outras drogas
A ciência evolui em diversos domínios, desde novas descobertas que tornam obsoletos achados anteriores à modificação de termos que se tornam inadequados em um determinado momento histórico. Na área de saúde mental, por exemplo, a criança “excepcional” passou a ser chamada de “criança com deficiência intelectual”, e o “esquizofrênico” passou a ser chamado de “pessoa com esquizofrenia”.2 A adequação da linguagem na área de saúde mental não se deve meramente ao politicamente correto, pois esta expressão remete a palavras que são utilizadas em contextos sociais apenas para mascarar o preconceito, e não para combatê-lo.
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 30 (1) , e2020921
Open AccessA linguagem e o estigma: os termos utilizados na área de álcool e outras drogas
A ciência evolui em diversos domínios, desde novas descobertas que tornam obsoletos achados anteriores à modificação de termos que se tornam inadequados em um determinado momento histórico. Na área de saúde mental, por exemplo, a criança “excepcional” passou a ser chamada de “criança com deficiência intelectual”, e o “esquizofrênico” passou a ser chamado de “pessoa com esquizofrenia”.2 A adequação da linguagem na área de saúde mental não se deve meramente ao politicamente correto, pois esta expressão remete a palavras que são utilizadas em contextos sociais apenas para mascarar o preconceito, e não para combatê-lo.